28268114|t|S. mansoni - T. cruzi co-infection modulates arginase-1 / iNOS expression, liver and heart disease in mice
28268114|a|Although Schistosoma species and Trypanosoma cruzi share common endemic areas, co-infections by these parasites remains overlooked. By using a murine model of S. mansoni and T. cruzi co-infection, we investigated if and to what extent these infections might interact to change the pathological outcomes typically observed when the host is infected by a single parasite species. Swiss mice were randomized into four groups: uninfected (NI) and those infected by S. mansoni (SM), T. cruzi (TC) or co-infected (SM + TC). After 120 days of S. mansoni infection, T. cruzi was concurrently inoculated and the infection occurred for 30 days. Taken together, we identified that the overlap of Th2 (schistosomiasis) and Th1 (Chagas disease) immunological patterns changes the host resistance against both pathogens. Beyond impairing the control of granulomatous inflammation, T. cruzi parasitemia and parasitism in co-infected animals, the Th2 inflammatory response against S. mansoni elicits the activation of the arginase-1 pathway to the detriment of inducible oxide nitric synthase (iNOS) expression and nitric oxide (NO) production, contributing to the liver damage, with minor effects on heart pathology.
28268114	0	10	S. mansoni	T204	C0036319
28268114	13	21	T. cruzi	T204	C0041221
28268114	22	34	co-infection	T047	C0275524
28268114	35	44	modulates	T082	C0443264
28268114	45	55	arginase-1	T116,T126	C2743700
28268114	58	62	iNOS	T116,T126	C1565683
28268114	63	73	expression	T045	C1171362
28268114	75	80	liver	T047	C0023895
28268114	85	98	heart disease	T047	C0018799
28268114	102	106	mice	T015	C0025929
28268114	116	135	Schistosoma species	T204	C0036319
28268114	140	157	Trypanosoma cruzi	T204	C0041221
28268114	171	184	endemic areas	T033	C2732661
28268114	186	199	co-infections	T047	C0275524
28268114	209	218	parasites	T204	C0030498
28268114	250	262	murine model	T075	C0026339
28268114	266	276	S. mansoni	T204	C0036319
28268114	281	289	T. cruzi	T204	C0041221
28268114	290	302	co-infection	T047	C0275524
28268114	307	319	investigated	T169	C1292732
28268114	348	358	infections	T046	C3714514
28268114	388	400	pathological	T169	C1521733
28268114	401	409	outcomes	T169	C1274040
28268114	420	428	observed	T169	C1441672
28268114	438	442	host	T001	C1167395
28268114	446	454	infected	T046	C3714514
28268114	467	475	parasite	T204	C0030498
28268114	476	483	species	T185	C1705920
28268114	485	495	Swiss mice	T015	C0162416
28268114	501	511	randomized	T062	C0034656
28268114	522	528	groups	T078	C0441833
28268114	530	540	uninfected	T169	C0521118
28268114	542	544	NI	T169	C0521118
28268114	568	578	S. mansoni	T204	C0036319
28268114	580	582	SM	T204	C0036319
28268114	585	593	T. cruzi	T204	C0041221
28268114	595	597	TC	T204	C0041221
28268114	602	613	co-infected	T047	C0275524
28268114	615	617	SM	T204	C0036319
28268114	620	622	TC	T204	C0041221
28268114	643	653	S. mansoni	T204	C0036319
28268114	654	663	infection	T046	C3714514
28268114	665	673	T. cruzi	T204	C0041221
28268114	691	701	inoculated	T061	C2987620
28268114	710	719	infection	T046	C3714514
28268114	781	788	overlap	T079	C1948020
28268114	792	795	Th2	T025	C0242633
28268114	797	812	schistosomiasis	T047	C0036323
28268114	818	821	Th1	T025	C0242632
28268114	823	837	Chagas disease	T047	C0041234
28268114	839	852	immunological	T169	C0205470
28268114	853	861	patterns	T082	C0449774
28268114	874	878	host	T001	C1167395
28268114	879	889	resistance	T039	C1514892
28268114	903	912	pathogens	T001	C0450254
28268114	921	930	impairing	T169	C0221099
28268114	935	942	control	T169	C2587213
28268114	946	972	granulomatous inflammation	T046	C0553697
28268114	974	982	T. cruzi	T204	C0041221
28268114	983	994	parasitemia	T047	C0242723
28268114	999	1009	parasitism	T070	C0677482
28268114	1013	1024	co-infected	T047	C0275524
28268114	1025	1032	animals	T008	C0003062
28268114	1038	1041	Th2	T025	C0242633
28268114	1042	1063	inflammatory response	T046	C1155266
28268114	1072	1082	S. mansoni	T204	C0036319
28268114	1095	1105	activation	T052	C1879547
28268114	1113	1123	arginase-1	T116,T126	C2743700
28268114	1124	1131	pathway	T077	C1705987
28268114	1139	1148	detriment	T169	C1883709
28268114	1152	1183	inducible oxide nitric synthase	T116,T126	C1565683
28268114	1185	1189	iNOS	T116,T126	C1565683
28268114	1191	1201	expression	T045	C1171362
28268114	1206	1218	nitric oxide	T121,T123,T197	C0028128
28268114	1220	1222	NO	T121,T123,T197	C0028128
28268114	1224	1234	production	T057	C0033268
28268114	1256	1268	liver damage	T046	C0151763
28268114	1275	1280	minor	T080	C0205165
28268114	1281	1288	effects	T080	C2348382
28268114	1292	1297	heart	T023	C0018787
28268114	1298	1307	pathology	T091	C0030664